SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 5,917.37 |
Enterprise Value ($M) | 5,548.12 |
Book Value ($M) | 1,121.13 |
Book Value / Share | 17.09 |
Price / Book | 5.28 |
NCAV ($M) | 1,111.94 |
NCAV / Share | 16.95 |
Price / NCAV | 5.32 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.20 |
Return on Assets (ROA) | -0.53 |
Return on Equity (ROE) | -0.57 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 23.07 |
Current Ratio | 23.07 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,179.67 |
Assets | 1,188.86 |
Liabilities | 67.73 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Paradigm Biocapital Advisors LP | 7.80 | 29.60 | |
13G/A | Perceptive Advisors Llc | 4.60 | 2.10 | |
13G | BlackRock, Inc. | 5.60 | 0.00 | |
13G/A | Flynn James E | 33.99 | 0.40 | |
13D/A | Bain Capital Life Sciences Fund II, L.P. | 4.10 | 0.00 | |
13G/A | Fairmount Funds Management LLC | 3.40 | -30.99 | |
13G | Vanguard Group Inc | 5.72 | ||
13G/A | Fmr Llc | 14.94 | 14.51 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
207,070 | 682,830 | 30.33 | |
88,719 | 377,041 | 23.53 | |
77,422 | 436,053 | 17.76 | |
33,431 | 293,133 | 11.40 | |
21,250 | 238,788 | 8.90 | |
(click for more detail) |
Similar Companies | |
---|---|
NEOG – Neogen Corporation | NKTX – Nkarta, Inc. |
NMRA – Neumora Therapeutics, Inc. | NVAX – Novavax, Inc. |
NXTC – NextCure, Inc. |
Financial data and stock pages provided by
Fintel.io